New device advances the treatment of heart arrhythmias
Florida Hospital Waterman offers world’s least invasive implantable defibrillator
TAVARES, Fla. (May 29, 2014) –A new device available first in Lake County at Florida Hospital Waterman is helping patients achieve greater protection from complications caused by heart rhythm disturbances. Life threatening heart arrhythmias affect more than 4 million Americans, according to the American Heart Association. The new electrophysiology (EP) device is the least invasive implantable defibrillator available, and can provide patients with a new option that reduces their risk of complications and damage to the heart and its surrounding vessels. EP devices monitor and detect rhythm disturbances and deliver electrical stimulations helping to protect against life-threatening arrhythmias.
The subcutaneous implantable defibrillator (S-ICD) system by Boston Scientific is the world's first and only ICD which is implanted external of the heart. This system is placed just under the skin and leaves the heart and blood vessels untouched. Unlike its more invasive counterpart, this innovative ICD device does not use insulated wires, known as leads, to provide the electrical shock, but rather a combination of a pulse generator and an electrode which surround the heart.
“This innovative technology is paving the way for better outcomes and improved quality of life for our cardiac patients,” said Miguel Bryce, M.D., Medical Director of Electrophysiology, Florida Hospital Waterman. “The device is clinically proven to provide patients with the same reliable protection as a traditional ICD but with a decreased chance of complications and potential damage to the heart and its surrounding area.”
In addition, the smallest implantable cardiac monitoring device on the market, the Medtronics Reveal LINQ Insertable Cardiac Monitoring (ICM), has also been made available to patients. The cardiac monitor is approximately one-third the size of a AAA batter, making it more than 80 percent smaller than other ICMs. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 percent more data memory than larger devices. The ICM is implanted just beneath the skin using a minimally invasive procedure. Once implanted, the device continuingly gathers large amount of data based on the rhythms of the heart. That data can be delivered directly, in real time to the physician upon request to help explain the occurrence of symptoms such as dizziness, palpitation, fainting and chest pain that may suggest a cardiac arrhythmia.
“The new device allows us to more effectively monitor a patient’s heart and correlate the large amount of data collected to tailor the patient’s treatment based on their unique heart issues,” said Bryce.
Both of these procedures were performed in the newly renovated cardiac catheterization and electrophysiology (EP) lab at Florida Hospital Waterman. Approximately 500 procedures are performed in the EP lab annually. For more information on the services and treatments available at the Florida Hospital Waterman Heart Center visit FHWatermanHeart.com.